Bioactive Services USA, LLC / Herstat Inc. — FDA Enforcement History

FDA action counts

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Bioactive Services USA, LLC / Herstat Inc. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-10-01, Argus HQ recorded an FDA Warning Letter for Bioactive Services USA, LLC / Herstat Inc., rated "critical" severity in Argus HQ's classification: Bioactive Services USA, LLC / Herstat Inc. — Unapproved New Drugs (2026-10-01). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

Is this FDA enforcement data for Bioactive Services USA, LLC / Herstat Inc. official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Bioactive Services USA, LLC / Herstat Inc. had?

Argus HQ has recorded 1 FDA events for Bioactive Services USA, LLC / Herstat Inc.: 1 warning letters, 0 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

What is the most recent FDA action against Bioactive Services USA, LLC / Herstat Inc.?

The most recent FDA event Argus HQ has on file for Bioactive Services USA, LLC / Herstat Inc. is dated 2026-10-01, with a severity rating of "critical" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Bioactive Services USA, LLC / Herstat Inc. automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Bioactive Services USA, LLC / Herstat Inc. is observed, this page's event count and history update automatically.

Related enforcement actions

• Bioactive Services USA, LLC / Herstat Inc. — Unapproved New Drugs (2026-10-01) →

Compare with

• Bioactive Services USA, LLC / Herstat Inc. vs Philips North America
• Bioactive Services USA, LLC / Herstat Inc. vs Medline Industries, LP
• Bioactive Services USA, LLC / Herstat Inc. vs Boston Scientific Corporation
• Bioactive Services USA, LLC / Herstat Inc. vs Baxter Healthcare Corporation
• Bioactive Services USA, LLC / Herstat Inc. vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.